Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

US10941205B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Harald Duerr · Starnberg, DE
• Sebastian Fenn · Clapham, GB
• Ulrich Goepfert · Penzberg, DE
• Sabine Imhof-Jung · Planegg, DE
• Christian Klein · Iffeldorf, DE
• Laurent Lariviere · Ostendorf, DE
• Michael Molhoj · Munich, DE
• Joerg Thomas Regula · Munich, DE
• Petra Rueger · Penzberg, DE
• Wolfgang Schaefer · Sankt Augustin, DE

Key dates

• Filing date: Mar 30, 2018
• Grant date: Mar 9, 2021
• Expiry date: Mar 30, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/64
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Herein are provided bispecific anti-human A-beta/human transferrin receptor antibodies and methods of using the same.